๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV ยท Real-Time Price ยท USD
1.400
-0.160 (-10.26%)
At close: Nov 19, 2026, 4:00 PM EST
1.427
+0.027 (1.93%)
After-hours: Nov 19, 2026, 7:30 PM EST

Acrivon Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-77.2-84.11-89.2-67.1-32.66-16.18
Net Income
-73.89-77.91-80.56-60.39-31.17-16.24
Earnings Per Share
-1.82-2.02-2.38-2.74-7.56-9.32
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
77.75118.58179.48127.46127.7599.6
Total Debt
1.82.713.654.644.965.63
Net Cash (Debt)
75.95115.87175.84122.81122.7993.98
Net Cash Growth
-39.85%-34.10%43.17%0.02%30.66%6062.30%
Net Cash Per Share
1.873.015.205.5629.7953.90

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-63.02-63.67-65.67-42.64-30.12-13.98
Capital Expenditures
-0.32-1.67-2.77-1.29-2.17-0.24
Free Cash Flow
-63.34-65.33-68.44-43.93-32.28-14.22
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.